EICHORPublic-registry site landscape for NCT05306418, “A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors”, a Haemophilia A With or Without Inhibitors study sponsored by Novo Nordisk A/S. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05306418 (registry record) |
| Study title | A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors |
| Official title | Safety, Efficacy and Exposure of Subcutaneously Administered NNC0365-3769 (Mim8) Prophylaxis in Children With Haemophilia A With or Without FVIII Inhibitors |
| Sponsor | Novo Nordisk A/S |
| Condition(s) | Haemophilia A With or Without Inhibitors |
| Phase | PHASE3 |
| Listed sites | 52 |
| Site countries | United States, Canada, China, Germany, India, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Portugal |
Patient-friendly overview of this study: eichor.com/study/NCT05306418.
Eichor generates a preliminary site-risk snapshot for NCT05306418 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
More from Novo Nordisk A/S
← Eichor home · All tracked trials · Haemophilia A With or Without Inhibitors studies · Weekly briefs
